Ravi Agrawal, a promoter of Ajanta Pharma Limited, has released a pledge on 1,050,000 equity shares of the company. This release of pledge, dated November 12, 2025, is due to excess pledge. Post release, Ravi Agrawal, trustee Ravi Agrawal Trust, holds 6,063,920 shares encumbered, representing 4.85% of total share capital.
Pledge Release Announcement
On November 12, 2025, Ajanta Pharma Limited announced the release of a pledge on a significant number of equity shares. The promoter, Ravi Agrawal, acting as trustee of Ravi Agrawal Trust, executed the release.
Details of the Share Release
The pledge was released on 1,050,000 equity shares. The stated reason for this release is due to the existence of an excess pledge.
Post-Release Encumbrance Status
Following this transaction, Ravi Agrawal, trustee Ravi Agrawal Trust, continues to hold 6,063,920 encumbered shares, which now represents 4.85% of the company’s total share capital. Lenders involved are Bajaj Finance Limited and Barclays Securities India Pvt Ltd, Julius Baer Wealth Advisors (India) Pvt. Ltd.
Impact on Promoter Holdings
Other promoter holdings include:
- Gabs Investments Pvt Ltd: No change in encumbrance.
- Yogesh M Agrawal, trustee Yogesh Agrawal Trust: No change in encumbrance.
- Rajesh M Agrawal, trustee Rajesh Agrawal Trust: No change in encumbrance.
- Aayush M Agrawal, trustee Aayush Agrawal Trust now holds 6,580,002 shares encumbered representing 5.27%.
Source: BSE
